Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2017 1
2018 1
2019 2
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story.
García-Cano J, Roche O, Cimas FJ, Pascual-Serra R, Ortega-Muelas M, Fernández-Aroca DM, Sánchez-Prieto R. García-Cano J, et al. Among authors: ortega muelas m. Front Cell Dev Biol. 2016 Jun 30;4:69. doi: 10.3389/fcell.2016.00069. eCollection 2016. Front Cell Dev Biol. 2016. PMID: 27446920 Free PMC article. Review.
p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models.
Pascual-Serra R, Fernández-Aroca DM, Sabater S, Roche O, Andrés I, Ortega-Muelas M, Arconada-Luque E, Garcia-Flores N, Bossi G, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Pascual-Serra R, et al. Among authors: ortega muelas m. Radiother Oncol. 2021 Mar;156:136-144. doi: 10.1016/j.radonc.2020.12.008. Epub 2020 Dec 11. Radiother Oncol. 2021. PMID: 33310004
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.
Arconada-Luque E, Jiménez-Suarez J, Pascual-Serra R, Nam-Cha SH, Moline T, Cimas FJ, Fliquete G, Ortega-Muelas M, Roche O, Fernández-Aroca DM, Muñoz Velasco R, García-Flores N, Garnés-García C, Sánchez-Fdez A, Matilla-Almazán S, Sánchez-Arévalo Lobo VJ, Hernández-Losa J, Belandia B, Pandiella A, Esparís-Ogando A, Ramón Y Cajal S, Del Peso L, Sánchez-Prieto R, Ruiz-Hidalgo MJ. Arconada-Luque E, et al. Among authors: ortega muelas m. Cancers (Basel). 2022 Jul 19;14(14):3509. doi: 10.3390/cancers14143509. Cancers (Basel). 2022. PMID: 35884568 Free PMC article.
E1a is an exogenous in vivo tumour suppressor.
Cimas FJ, Callejas-Valera JL, García-Olmo DC, Hernández-Losa J, Melgar-Rojas P, Ruiz-Hidalgo MJ, Pascual-Serra R, Ortega-Muelas M, Roche O, Marcos P, Garcia-Gil E, Fernandez-Aroca DM, Ramón Y Cajal S, Gutkind JS, Sanchez-Prieto R. Cimas FJ, et al. Among authors: ortega muelas m. Cancer Lett. 2017 Jul 28;399:74-81. doi: 10.1016/j.canlet.2017.04.010. Epub 2017 Apr 15. Cancer Lett. 2017. PMID: 28416454
HIF1α Suppresses Tumor Cell Proliferation through Inhibition of Aspartate Biosynthesis.
Meléndez-Rodríguez F, Urrutia AA, Lorendeau D, Rinaldi G, Roche O, Böğürcü-Seidel N, Ortega Muelas M, Mesa-Ciller C, Turiel G, Bouthelier A, Hernansanz-Agustín P, Elorza A, Escasany E, Li QOY, Torres-Capelli M, Tello D, Fuertes E, Fraga E, Martínez-Ruiz A, Pérez B, Giménez-Bachs JM, Salinas-Sánchez AS, Acker T, Sánchez Prieto R, Fendt SM, De Bock K, Aragonés J. Meléndez-Rodríguez F, et al. Among authors: ortega muelas m. Cell Rep. 2019 Feb 26;26(9):2257-2265.e4. doi: 10.1016/j.celrep.2019.01.106. Cell Rep. 2019. PMID: 30811976 Free article.
ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology.
Ortega-Muelas M, Roche O, Fernández-Aroca DM, Encinar JA, Albandea-Rodríguez D, Arconada-Luque E, Pascual-Serra R, Muñoz I, Sánchez-Pérez I, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Ortega-Muelas M, et al. J Cell Mol Med. 2021 Nov;25(22):10591-10603. doi: 10.1111/jcmm.16990. Epub 2021 Oct 16. J Cell Mol Med. 2021. PMID: 34655447 Free PMC article.
Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance.
García-Cano J, Ambroise G, Pascual-Serra R, Carrión MC, Serrano-Oviedo L, Ortega-Muelas M, Cimas FJ, Sabater S, Ruiz-Hidalgo MJ, Sanchez Perez I, Mas A, Jalón FA, Vazquez A, Sánchez-Prieto R. García-Cano J, et al. Among authors: ortega muelas m. Oncotarget. 2015 Jun 20;6(17):15551-65. doi: 10.18632/oncotarget.3902. Oncotarget. 2015. PMID: 26036632 Free PMC article.
Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion.
Serrano-Oviedo L, Ortega-Muelas M, García-Cano J, Valero ML, Cimas FJ, Pascual-Serra R, Fernandez-Aroca DM, Roche O, Ruiz-Hidalgo MJ, Belandia B, Giménez-Bachs JM, Salinas AS, Sanchez-Prieto R. Serrano-Oviedo L, et al. Among authors: ortega muelas m. PLoS One. 2018 Jul 26;13(7):e0200878. doi: 10.1371/journal.pone.0200878. eCollection 2018. PLoS One. 2018. PMID: 30048489 Free PMC article.